= candidate completed the Ballotpedia Candidate Connection survey. If you are a candidate and would like to tell readers and voters more about why they should vote for you, complete the Ballotpedia ...

Let’s get one thing out of the way: the new Philippine polymer currency design looks vibrant and exciting. The fauna aspects of Philippine biodiversity ...

Several positional mismatches are to blame for the Pittsburgh Steelers’ Week 18 loss, and one of the biggest was CB Cory Trice Jr. versus WR Ja’Marr Chase. Trice, positioning himself as the ...

Aetna is taking legal action against Pfizer, Novartis, Teva Pharmaceuticals and others, saying the list of drugmakers conspired to overcharge the insurer, consumers and the federal government for ...

To hear Novo tell it, the outsourcing group OFA shouldn’t be allowed to place liraglutide on its compounding list given that FDA-approved generics to Victoza are available. Further, the OFA has ...

The electric vehicle (EV) industry is bracing up for an electrifying showdown in 2025 as two heavyweights — U.S.-based Tesla TSLA and China’s BYD Co. Ltd. BYDDY — vie for global supremacy.

Will 2025 be better? After another tough year, the answer to that question will shape the prospects of innumerable drug candidates and the lives of people who work in biotech. Evaluate analysts ...

MANILA, Philippines — The local stock market was off to a good start this year, finishing the first trading session of 2025 in positive territory. Also closing higher by 0.18 percent or 6.59 ...

Do you want a spreadsheet of this type of data? Contact our sales team. Incumbent Mario Diaz-Balart defeated Darren Dione Aquino in the Republican primary for U.S. House Florida District 26 on August ...

Marinus Pharmaceuticals, working through a tumultuous period marked by two phase 3 blows, layoffs and a shareholder lawsuit, has inked an end-of-year sale to Immedica Pharma AB worth $151 million.

Neumora Therapeutics’ big bet on a new era of neuroscience has delivered an age-old result. The first of three late-stage readouts on Neumora’s lead drug candidate has ended in failure, wiping ...